Primary Site >> Biliary tract Cancer
Gene >> PRKAR1A
| 1. | |||||||||||
| Journal: | Mol Carcinog. 2006 May;45(5):279-87. | ||||||||||
| Title: | Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. | ||||||||||
| Author: | Loilome, Watcharin|Yongvanit, Puangrat|Wongkham, Chaisiri|Tepsiri, Nisana|Sripa, Banchob|Sithithaworn, Paiboon|Hanai, Shuji|Miwa, Masanao | ||||||||||
| PMID: | 16550611 | ||||||||||
| 2. | |||||||||||
| Journal: | Tumour Biol. 2012 Dec;33(6):2289-98. | ||||||||||
| Title: | PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. | ||||||||||
| Author: | Loilome, Watcharin|Yooyuen, Sasithorn|Namwat, Nisana|Sithithaworn, Paiboon|Puapairoj, Anucha|Kano, Junko|Noguchi, Masayuki|Miwa, Masanao|Yongvanit, Puangrat | ||||||||||
| PMID: | 22922884 | ||||||||||
| 3. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2012;13 Suppl:143-7. | ||||||||||
| Title: | Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. | ||||||||||
| Author: | Loilome, Watcharin|Juntana, Sirinun|Pinitsoontorn, Chadamas|Namwat, Nisana|Tassaneeyakul, Wichittra|Yongvanit, Puangrat | ||||||||||
| PMID: | 23480756 | ||||||||||
| 4. | |||||||||||
| Journal: | Am J Cancer Res. 2018 Jan 1;8(1):2-15. eCollection 2018. | ||||||||||
| Title: | Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers. | ||||||||||
| Author: | Papadopoulou, Kyriaki|Murray, Samuel|Manousou, Kyriaki|Tikas, Ioannis|Dervenis, Christos|Sgouros, Joseph|Rontogianni, Dimitra|Lakis, Sotirios|Bobos, Mattheos|Poulios, Christos|Pervana, Stavroula|Lazaridis, Georgios|Fountzilas, George|Kotoula, Vassiliki | ||||||||||
| PMID: | 29416916 | ||||||||||